Dimensional Fund Advisors LP boosted its position in shares of John Wiley & Sons, Inc. (NYSE:WLY – Free Report) by 4.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,924,498 shares of the company’s stock after purchasing an additional 90,693 shares during the quarter. Dimensional Fund Advisors LP owned approximately 3.54% of John Wiley & Sons worth $78,326,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of WLY. GAMMA Investing LLC boosted its stake in shares of John Wiley & Sons by 96.9% during the first quarter. GAMMA Investing LLC now owns 754 shares of the company’s stock valued at $29,000 after acquiring an additional 371 shares during the last quarter. Adirondack Trust Co. raised its position in shares of John Wiley & Sons by 23.5% in the 4th quarter. Adirondack Trust Co. now owns 2,100 shares of the company’s stock worth $70,000 after buying an additional 400 shares during the period. Penbrook Management LLC acquired a new stake in John Wiley & Sons during the first quarter worth about $210,000. Bayesian Capital Management LP acquired a new stake in John Wiley & Sons during the 1st quarter worth approximately $212,000. Finally, Oppenheimer & Co. Inc. purchased a new stake in John Wiley & Sons during the 1st quarter worth $226,000. Hedge funds and other institutional investors own 73.94% of the company’s stock.
John Wiley & Sons Price Performance
WLY stock opened at $47.14 on Friday. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.53 and a current ratio of 0.57. John Wiley & Sons, Inc. has a 1 year low of $28.83 and a 1 year high of $49.20. The stock has a 50-day simple moving average of $46.11 and a 200-day simple moving average of $41.47. The firm has a market cap of $2.56 billion, a P/E ratio of -12.95 and a beta of 0.86.
About John Wiley & Sons
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
See Also
- Five stocks we like better than John Wiley & Sons
- Bank Stocks – Best Bank Stocks to Invest In
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- The Risks of Owning Bonds
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- 3 Monster Growth Stocks to Buy Now
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.